| Literature DB >> 36186096 |
Jang Won Lee1, Jinseub Hwang2, Min Kyung Hyun1.
Abstract
Objectives: Child and adolescent sleep is an important factor for brain and physical development. Therefore, it is necessary to investigate the prevalence of sleep disorders and nonorganic sleep disorders in children and adolescents and determine the type of utilization of medical institutions. This study analyzed the prevalence and type of medical institutions in Korean children and adolescents with sleep disorders and nonorganic sleep disorders.Entities:
Keywords: acupuncture; herbal medicine; korean medicine; nonorganic sleep disorders; sleep disorders
Year: 2022 PMID: 36186096 PMCID: PMC9510137 DOI: 10.3831/KPI.2022.25.3.276
Source DB: PubMed Journal: J Pharmacopuncture ISSN: 2093-6966
Figure 1Patients selection process.
Figure 2Prevalence of sleep disorders (A) and nonorganic sleep disorders (B) among children aged 0-19.
Prevalence of sleep disorders and nonorganic sleep disorders in Korean children aged 0-19 years
| Total (N) | Sleep disorders | Nonorganic sleep disorders | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
| |||||||||||||||||||||
| Total | Male | Female | Total | Male | Female | Total | Male | Female | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||||||
| n | n | n | n | % | n | % | n | % | n | % | n | % | n | % | |||||||||
| Total | 2,536,478 | 1,307,636 | 1,228,842 | 2,074 | 0.08 | 1,140 | 0.09 | 934 | 0.08 | 1,685 | 0.07 | 907 | 0.07 | 778 | 0.06 | ||||||||
| Year | |||||||||||||||||||||||
| 2010 | 339,323 | 175,921 | 163,402 | 228 | 0.07 | 120 | 0.07 | 108 | 0.07 | 260 | 0.08 | 136 | 0.08 | 124 | 0.08 | ||||||||
| 2011 | 332,942 | 172,270 | 160,672 | 261 | 0.08 | 148 | 0.09 | 113 | 0.07 | 254 | 0.08 | 137 | 0.08 | 117 | 0.07 | ||||||||
| 2012 | 327,936 | 169,369 | 158,567 | 269 | 0.08 | 140 | 0.08 | 129 | 0.08 | 228 | 0.07 | 134 | 0.08 | 94 | 0.06 | ||||||||
| 2013 | 320,049 | 164,930 | 155,119 | 244 | 0.08 | 113 | 0.07 | 131 | 0.08 | 193 | 0.06 | 106 | 0.06 | 87 | 0.06 | ||||||||
| 2014 | 314,441 | 161,929 | 152,512 | 281 | 0.09 | 147 | 0.09 | 134 | 0.09 | 214 | 0.07 | 113 | 0.07 | 101 | 0.07 | ||||||||
| 2015 | 307,389 | 158,003 | 149,386 | 272 | 0.09 | 157 | 0.10 | 115 | 0.08 | 192 | 0.06 | 115 | 0.07 | 77 | 0.05 | ||||||||
| 2016 | 301,505 | 154,898 | 146,607 | 271 | 0.09 | 168 | 0.11 | 103 | 0.07 | 181 | 0.06 | 87 | 0.06 | 94 | 0.06 | ||||||||
| 2017 | 292,893 | 150,316 | 142,577 | 248 | 0.08 | 147 | 0.10 | 101 | 0.07 | 163 | 0.06 | 79 | 0.05 | 84 | 0.06 | ||||||||
Figure 3Proportion of types of medical utilization by age in children and adolescents with sleep disorders (A) and nonorganic sleep disorders (B).
Characteristics of patients with sleep disorders according to the utilization of conventional and Korean medicine
| Total | CM alone | KM alone | ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||
| n | % | n | % | n | % | |||
| Total | 2,074 | 100.00 | 1,439 | 69.38 | 635 | 30.62 | ||
| Age | ||||||||
| 0-2 | 281 | 13.55 | 133 | 9.24 | 148 | 23.31 | ||
| 3-5 | 163 | 7.86 | 115 | 7.99 | 48 | 7.56 | ||
| 6-9 | 166 | 8.00 | 73 | 5.07 | 93 | 14.65 | ||
| 10-12 | 137 | 6.61 | 68 | 4.73 | 69 | 10.87 | ||
| 13-19 | 1,327 | 63.98 | 1,050 | 72.97 | 277 | 43.62 | ||
| Gender | ||||||||
| Male | 1,140 | 54.97 | 832 | 57.82 | 308 | 48.50 | ||
| Female | 934 | 45.03 | 607 | 42.18 | 327 | 51.50 | ||
| Use of outpatient service | ||||||||
| Mean ± sd | 2.32 ± 2.84 | 2.16 ± 2.37 | 2.69 ± 3.66 | |||||
| Median (Q1, Q3) | 1 (1, 31) | 1 (0, 27) | 1 (1, 31) | |||||
| Follow-up period (day) | ||||||||
| Mean ± sd | 196.73 ± 109.12 | 195.19 ± 110.07 | 200.22 ± 106.94 | |||||
| Median (Q1, Q3) | 195 (107, 301) | 194 (99.5, 299) | 197 (115.5, 302.5) | |||||
| Diagnostic code | ||||||||
| Insomnias | 903 | 43.54 | 452 | 31.41 | 451 | 71.02 | ||
| Hypersomnias | 88 | 4.24 | 79 | 5.49 | 9 | 1.42 | ||
| Disorders of the sleep-wake schedule | 21 | 1.01 | 19 | 1.32 | 2 | 0.31 | ||
| Sleep apnoea | 408 | 19.67 | 403 | 28.01 | 5 | 0.79 | ||
| Narcolepsy and cataplexy | 117 | 5.64 | 116 | 8.06 | 1 | 0.16 | ||
| Other sleep disorders | 169 | 8.15 | 114 | 7.92 | 55 | 8.66 | ||
| Sleep disorder, unspecified | 368 | 17.74 | 256 | 17.79 | 112 | 17.64 | ||
| Year | ||||||||
| 2010 | 228 | 10.99 | 154 | 10.70 | 74 | 11.65 | ||
| 2011 | 261 | 12.58 | 180 | 12.51 | 81 | 12.76 | ||
| 2012 | 269 | 12.97 | 187 | 13.00 | 82 | 12.91 | ||
| 2013 | 244 | 11.76 | 173 | 12.02 | 71 | 11.18 | ||
| 2014 | 281 | 13.55 | 203 | 14.11 | 78 | 12.28 | ||
| 2015 | 272 | 13.11 | 198 | 13.76 | 74 | 11.65 | ||
| 2016 | 271 | 13.07 | 186 | 12.93 | 85 | 13.39 | ||
| 2017 | 248 | 11.96 | 158 | 10.98 | 90 | 14.17 | ||
Treatment type of patients with sleep disorders according to the utilization of Korean medicine
| Acupuncture | Herbal medicine | Moxibustion | Cupping | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||||||||
| n (%) | N of prescription | Follow-up period | n (%) | N of prescription | Follow-up period | n (%) | N of prescription | Follow-up period | n (%) | N of prescription | Follow-up period | ||||
| Total | 553 (100.0) | 4.96 ±8.66 | 199.40 ±107.55 | 71 (100.0) | 1.69 ±1.83 | 215.76 ±105.07 | 149 (100.0) | 3.20 ±4.93 | 190.98 ±112.05 | 79 (100.0) | 4.04 ±5.50 | 200.98 ±105.64 | |||
| Age | |||||||||||||||
| 0-2 | 132 (23.87) | 2.64 ±3.84 | 195.71 ±108.45 | 14 (19.72) | 2.50 ±3.70 | 202.43 ±89.56 | 8 | 2.88 ±3.36 | 90.88 ±107.40 | 8 (10.13) | 2.25 ±1.75 | 173.63 ±112.25 | |||
| 3-5 | 41 (7.41) | 4.37 ±5.95 | 190.24 ±99.59 | 7 | 1.43 ±0.54 | 139.43 ±84.14 | 9 | 1.56 ±1.01 | 185.44 ±131.28 | 3 | 4.67 ±5.51 | 159.00 ±130.93 | |||
| 6-9 | 80 (14.47) | 4.78 ±6.62 | 217.54 ±110.76 | 11 (15.49) | 1.27 ±0.47 | 265.27 ±84.06 | 17 (11.41) | 2.24 ±2.05 | 178.94 ±122.96 | 5 | 5.60 ±9.74 | 247.00 ±106.97 | |||
| 10-12 | 60 (10.85) | 4.95 ±7.59 | 208.55 ±155.49 | 12 (16.90) | 1.58 ±1.00 | 208.92 ±133.01 | 23 (15.44) | 3.65 ±5.74 | 230.26 ±109.39 | 7 | 2.57 ±2.23 | 211.00 ±143.82 | |||
| 13-19 | 240 (43.40) | 6.39 ±11.21 | 194.66 ±105.28 | 27 (38.03) | 1.56 ±1.09 | 225.33 ±105.16 | 92 (61.74) | 3.46 ±5.41 | 192.63 ±105.64 | 56 (70.89) | 4.30 ±5.74 | 201.77 ±100.50 | |||
| Gender | |||||||||||||||
| Male | 271 (49.01) | 4.52 ±6.91 | 203.69 ±106.13 | 24 (33.80) | 1.92 ±2.67 | 216.54 ±109.69 | 60 (40.27) | 2.92 ±4.00 | 180.17 ±112.65 | 47 (59.49) | 3.30 ±3.92 | 185.09 ±106.21 | |||
| Female | 282 (50.99) | 5.37 ±10.06 | 195.28 ±108.92 | 47 (66.20) | 1.57 ±1.23 | 215.36 ±103.85 | 89 (59.73) | 3.39 ±5.48 | 198.27 ±111.68 | 32 (40.51) | 5.13 ±7.17 | 224.31 ±101.97 | |||
| Diagnostic code | |||||||||||||||
| Insomnias | 392 (70.89) | 5.31 ±9.68 | 203.20 ±106.70 | 53 (74.65) | 1.81 ±2.09 | 216.32 ±103.35 | 120 (80.54) | 3.20 ±4.99 | 190.31 ±113.31 | 57 (72.15) | 4.07 ±5.48 | 205.39 ±107.39 | |||
| Hypersomnias | 5 | 3.60 ±3.58 | 244.20 ±103.51 | 0 | 2 | 2.50 ±2.12 | 199.00 ±104.65 | 1 | 1 | 273 | |||||
| Disorders of | 2 | 11.50 ±12.02 | 154.00 ±65.05 | 0 | 1 | 1.00 | 200.00 | 0 | |||||||
| Sleep apnoea | 5 | 1.80 ±1.30 | 294.80 ±55.39 | 0 | 0 | 1 | 1 | 352 | |||||||
| Narcolepsy and | 1 | 3.00 | 65.00 | 0 | 0 | 0 | |||||||||
| Other sleep | 49 (8.86) | 4.67 ±7.00 | 170.74 ±103.86 | 6 | 1.33 ±0.52 | 202.83 ±87.90 | 8 | 1.75 ±1.75 | 152.75 ±90.59 | 7 | 7.57 ±8.92 | 164.43 ±92.37 | |||
| Sleep disorder, | 99 (17.90) | 3.81 ±4.41 | 193.75 ±112.00 | 12 (16.90) | 1.33 ±0.65 | 219.75 ±127.03 | 18 (12.08) | 4.06 ±5.80 | 211.06 ±119.44 | 13 (16.46) | 2.46 ±2.30 | 184.15 ±104.64 | |||
| Year | |||||||||||||||
| 2010 | 64 (11.57) | 5.73 ±8.55 | 203.78 ±104.42 | 8 (11.27) | 1.63 ±1.41 | 192.38 ±103.14 | 14 | 2.93 ±2.90 | 180.57 ±111.97 | 8 (10.13) | 4.88 ±6.20 | 246.13 ±94.09 | |||
| 2011 | 74 (13.38) | 4.04 ±5.02 | 189.89 ±115.49 | 5 | 1.40 ±0.89 | 274.80 ±85.88 | 17 (11.41) | 2.71 ±2.66 | 177.00 ±125.25 | 4 | 3.75 ±3.59 | 185.75 ±164.20 | |||
| 2012 | 71 (12.84) | 4.70 ±7.78 | 215.00 ±112.14 | 8 (11.27) | 2.13 ±1.00 | 206.00 ±118.42 | 20 (13.42) | 3.20 ±5.96 | 171.25 ±121.65 | 6 | 4.33 ±5.28 | 246.67 ±104.50 | |||
| 2013 | 58 (10.49) | 5.10 ±13.56 | 196.14 ±101.29 | 12 (16.90) | 1.33 ±0.89 | 225.83 ±83.81 | 16 (10.74) | 4.69 ±7.55 | 206.69 ±102.30 | 3 | 11.33 ±17.04 | 163.67 ±29.50 | |||
| 2014 | 67 (12.12) | 3.82 ±4.06 | 194.03 ±106.76 | 10 (14.08) | 1.40 ±0.97 | 193.20 ±104.29 | 20 (13.42) | 1.85 ±1.31 | 232.05 ±102.29 | 10 (12.66) | 1.80 ±0.92 | 216.00 ±109.05 | |||
| 2015 | 67 (12.12) | 5.24 ±7.54 | 186.60 ±103.81 | 9 (12.68) | 2.67 ±4.27 | 217.78 ±121.13 | 16 (10.74) | 2.75 ±2.18 | 156.31 ±120.66 | 14 (17.72) | 3.79 ±4.35 | 184.14 ±111.53 | |||
| 2016 | 73 (13.20) | 5.59 ±10.02 | 206.88 ±104.89 | 9 (12.68) | 1.89 ±1.97 | 203.56 ±119.85 | 23 (15.44) | 2.96 ±4.79 | 192.00 ±99.65 | 13 (16.46) | 4.85 ±4.74 | 210.15 ±116.00 | |||
| 2017 | 79 (14.29) | 5.44 ±10.10 | 201.65 ±110.97 | 10 (14.08) | 1.20 ±0.42 | 232.40 ±120.29 | 23 (15.44) | 4.44 ±7.13 | 201.26 ±116.44 | 21 (26.58) | 3.38 ±5.36 | 177.33 ±96.98 | |||
Characteristics of patients with nonorganic sleep disorders according to the utilization of conventional and Korean medicine
| Total | CM alone | KM alone | ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||
| n | % | n | % | n | % | |||
| Total | 1,685 | 100.00 | 910 | 54.01 | 775 | 45.99 | ||
| Age | ||||||||
| 0-2 | 630 | 37.39 | 132 | 14.51 | 498 | 64.26 | ||
| 3-5 | 180 | 10.68 | 53 | 5.82 | 127 | 16.39 | ||
| 6-9 | 140 | 8.31 | 62 | 6.81 | 78 | 10.06 | ||
| 10-12 | 70 | 4.15 | 47 | 5.16 | 23 | 2.97 | ||
| 13-19 | 665 | 39.47 | 616 | 67.69 | 49 | 6.32 | ||
| Gender | ||||||||
| Male | 907 | 53.83 | 482 | 52.97 | 425 | 54.84 | ||
| Female | 778 | 46.17 | 428 | 47.03 | 350 | 45.16 | ||
| Use of outpatient service | ||||||||
| Mean ± sd | 2.63 ± 3.84 | 2.49 ± 3.67 | 2.80 ± 4.03 | |||||
| Median (Q1, Q3) | 1 (3, 42) | 1 (1, 37) | 1 (1, 42) | |||||
| Follow-up period (day) | ||||||||
| Mean ± sd | 195.81 ± 107.41 | 188.38 ± 107.76 | 204.54 ± 106.41 | |||||
| Median (Q1, Q3) | 197 (106, 295) | 184.5 (95, 285) | 214 (116.5, 303) | |||||
| Diagnostic code (except for 2017) | ||||||||
| Nonorganic insomnia | 413 | 27.14 | 343 | 42.88 | 70 | 9.70 | ||
| Nonorganic hypersomnia | 34 | 2.23 | 32 | 4.00 | 2 | 0.28 | ||
| Nonorganic disorder of | 16 | 1.05 | 14 | 1.75 | 2 | 0.28 | ||
| Somnambulism | 29 | 1.91 | 22 | 2.75 | 7 | 0.97 | ||
| Night terrors | 575 | 37.78 | 145 | 18.13 | 430 | 59.56 | ||
| Nightmares | 31 | 2.04 | 26 | 3.25 | 5 | 0.69 | ||
| Other nonorganic sleep disorders | 69 | 4.53 | 51 | 6.38 | 18 | 2.49 | ||
| Nonorganic sleep disorder, | 355 | 23.32 | 167 | 20.88 | 188 | 26.04 | ||
| Year | ||||||||
| 2010 | 260 | 15.43 | 114 | 12.53 | 146 | 18.84 | ||
| 2011 | 254 | 15.07 | 132 | 14.51 | 122 | 15.74 | ||
| 2012 | 228 | 13.53 | 124 | 13.63 | 104 | 13.42 | ||
| 2013 | 193 | 11.45 | 89 | 9.78 | 104 | 13.42 | ||
| 2014 | 214 | 12.70 | 120 | 13.19 | 94 | 12.13 | ||
| 2015 | 192 | 11.39 | 111 | 12.20 | 81 | 10.45 | ||
| 2016 | 181 | 10.74 | 110 | 12.09 | 71 | 9.16 | ||
| 2017 | 163 | 9.67 | 110 | 12.09 | 53 | 6.84 | ||
Treatment type of patients with nonorganic sleep disorders according to the utilization of Korean medicine
| Acupuncture | Herbal medicine | Moxibustion | Cupping | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||||||||
| n (%) | N of prescription | Follow-up period | n (%) | N of prescription | Follow-up period | n (%) | N of prescription | Follow-up period | n (%) | N of prescription | Follow-up period | ||||
| Total | 742 (100.0) | 3.31 ±5.86 | 203.40 ±106.82 | 61 (100.0) | 1.39 ±1.04 | 209.07 ±108.75 | 74 (100.0) | 3.62 ±6.34 | 209.27 ±113.88 | 70 (100.0) | 3.61 ±5.30 | 210.47 ±106.43 | |||
| Age | |||||||||||||||
| 0-2 | 484 (65.23) | 2.84 ±3.55 | 205.28 ±106.34 | 32 (52.46) | 1.44 ±0.95 | 221.44 ±104.29 | 26 (35.14) | 2.69 ±5.22 | 199.00 ±11.07 | 38 (54.29) | 4.34 ±5.48 | 210.37 ±98.65 | |||
| 3-5 | 120 (16.17) | 2.86 ±5.09 | 197.53 ±103.60 | 12 (19.67) | 1.17 ±0.39 | 209.25 ±104.61 | 8 (10.81) | 6.25 ±14.45 | 244.50 ±104.81 | 7 (10.00) | 2.14 ±2.19 | 252.43 ±103.82 | |||
| 6-9 | 71 (9.57) | 4.01 ±7.94 | 203.68 ±119.80 | 8 (13.11) | 1.13 ±0.35 | 195.38 ±139.28 | 16 (21.62) | 3.75 ±5.34 | 245.25 ±119.55 | 8 (11.43) | 1.63 ±1.06 | 263.88 ±54.72 | |||
| 10-12 | 21 (2.83) | 4.00 ±3.81 | 205.57 ±88.81 | 4 (6.56) | 1.00 ±0.00 | 210.25 ±121.91 | 6 | 2.50 ±3.21 | 173.67 ±86.00 | 1 | 6.00 | 268.00 | |||
| 13-19 | 46 (6.20) | 8.00 ±15.16 | 197.46 ±110.14 | 5 (8.20) | 2.40 ±2.61 | 150.40 ±109.69 | 18 (24.32) | 4.06 ±3.62 | 188.33 ±123.93 | 16 (22.86) | 3.38 ±6.91 | 162.06 ±131.64 | |||
| Gender | |||||||||||||||
| Male | 406 (54.72) | 3.36 ±6.57 | 205.38 ±105.15 | 25 (40.98) | 1.28 ±0.84 | 194.36 ±109.31 | 36 (48.65) | 3.00 ±3.42 | 194.69 ±105.97 | 35 (50.00) | 3.57 ±5.22 | 190.37 ±92.81 | |||
| Female | 336 (45.28) | 3.25 ±4.87 | 201.00 ±108.91 | 36 (59.02) | 1.47 ±1.16 | 219.28 ±108.72 | 38 (51.35) | 4.21 ±8.21 | 223.08 ±120.66 | 35 (50.00) | 3.66 ±5.46 | 230.57 ±116.37 | |||
| Diagnostic code | |||||||||||||||
| Nonorganic | 67 (9.03) | 5.09 ±10.09 | 186.02 ±110.13 | 12 (19.67) | 1.75 ±1.77 | 148.75 ±90.65 | 17 (22.97) | 3.88 ±4.53 | 169.00 ±118.86 | 12 (17.14) | 2.08 ±1.78 | 136.50 ±110.71 | |||
| Nonorganic | 2 | 5.50 ±3.54 | 93.00 ±25.46 | 0 (0.00) | 1 | 4.00 | 111.00 | 0 | |||||||
| Nonorganic | 2 | 1.50 ±0.71 | 150.50 ±202.94 | 0 (0.00) | 1 | 1.00 | 7.00 | 1 | 1.00 | 7 | |||||
| Somnambulism | 7 | 4.00 ±3.46 | 175.71 ±58.53 | 1 (1.64) | 1.00 | 139 | 2 | 1.00 | 156.00 ±31.11 | 0 | |||||
| Night terrors | 418 (56.33) | 2.62 ±3.22 | 198.78 ±107.20 | 29 (47.54) | 1.35 ±0.94 | 221.55 ±107.23 | 24 (32.43) | 2.38 ±3.33 | 214.38 ±107.75 | 17 (24.29) | 2.47 ±1.94 | 194.35 ±88.57 | |||
| Nightmares | 4 | 6.00 ±4.69 | 190.75 ±108.48 | 1 (1.64) | 1.00 | 53 | 0 | 0 | |||||||
| Other nonorganic | 16 (2.16) | 1.75 ±1.13 | 237.81 ±93.73 | 1 (1.64) | 1.00 | 332 | 2 | 1.00 | 249.50 ±115.26 | 1 | 1.00 | 168 | |||
| Nonorganic | 178 (23.99) | 4.10 ±8.04 | 215.54 ±106.53 | 14 (22.95) | 1.36 ±0.50 | 240.07 ±113.03 | 23 (31.08) | 3.96 ±5.96 | 238.13 ±113.44 | 33 (47.14) | 5.09 ±7.26 | 234.55 ±99.66 | |||
| Year | |||||||||||||||
| 2010 | 143 (19.27) | 2.48 ±2.80 | 187.47 ±104.79 | 14 (22.95) | 1.14 ±0.36 | 179.43 ±103.44 | 8 (10.81) | 2.88 ±3.83 | 195.00 ±108.78 | 5 | 2.00 ±2.24 | 153.40 ±95.15 | |||
| 2011 | 115 (15.50) | 2.37 ±2.80 | 206.08 ±99.06 | 10 (16.39) | 1.40 ±0.97 | 221.90 ±121.73 | 8 (10.81) | 2.13 ±2.10 | 203.38 ±113.76 | 2 | 1.50 ±0.71 | 245.00 ±108.89 | |||
| 2012 | 102 (13.75) | 3.70 ±7.74 | 200.55 ±107.26 | 8 (13.11) | 1.88 ±2.10 | 176.75 ±90.08 | 10 (13.51) | 2.60 ±2.91 | 186.50 ±125.07 | 8 (11.43) | 1.63 ±0.92 | 136.50 ±102.26 | |||
| 2013 | 100 (13.48) | 3.82 ±7.19 | 199.50 ±100.80 | 6 (9.84) | 1.17 ±0.41 | 239.33 ±133.91 | 11 (14.86) | 3.55 ±5.36 | 166.64 ±97.63 | 12 (17.14) | 4.58 ±5.71 | 210.50 ±84.00 | |||
| 2014 | 91 (12.26) | 3.98 ±4.68 | 206.78 ±113.81 | 6 (9.84) | 1.83 ±0.60 | 242.50 ±89.76 | 13 (17.57) | 3.31 ±4.29 | 200.08 ±146.08 | 10 (14.29) | 2.50 ±2.07 | 156.40 ±125.67 | |||
| 2015 | 73 (9.84) | 2.80 ±3.52 | 198.93 ±113.66 | 8 (13.11) | 1.50 ±0.76 | 209.63 ±127.17 | 12 (16.22) | 2.25 ±2.26 | 203.25 ±92.68 | 18 (25.71) | 3.06 ±2.73 | 207.78 ±97.38 | |||
| 2016 | 70 (9.43) | 4.39 ±9.96 | 227.86 ±115.19 | 6 (9.84) | 1.17 ±0.41 | 230.33 ±122.32 | 8 (10.81) | 6.00 ±8.98 | 312.38 ±58.00 | 9 (12.86) | 8.44 ±11.60 | 297.56 ±77.69 | |||
| 2017 | 48 (6.47) | 4.10 ±6.71 | 223.31 ±102.60 | 3 (4.92) | 1.00 | 219.33 ±111.50 | 4 | 11.25 ±20.50 | 265.50 ±110.62 | 6 | 2.67 ±1.63 | 312.67 ±40.84 | |||